Analyzing brain waveforms using neuroimaging big data helps improve diagnosis accuracy
A team of researchers from Osaka University and The University of Tokyo developed MNet, an automatic diagnosis system for neurological diseases using magnetoencephalography (MEG) (Figure 1), demonstrating the possibility of making automatic neurological disease diagnoses using MEG. Their research results were published in Scientific Reports.
MEG and electroencephalography (EEG) are essential for diagnosing neurological diseases such as epilepsy. MEG allows for the acquisition of detailed temporal-spatial patterns of human brain activity through the measurement of electro-magnetic field associated with neural activity, extracting detailed time-series signals from 160 sensors. Although information obtained from these tests is important for diagnosis, time and expertise are necessary for reading and analyzing, and abnormal waveform patterns may be missed.
Deep Neural Network (DNN), also known as deep learning, is a subset of machine learning in artificial intelligence (AI) and has drawn attention in recent years as a means for classifying data on various images, videos, and sounds at a high accuracy through a machine learning process using big data.
The AI-powered automatic classification system MNet, which utilizes DNN as a computational framework, is based on a neural network called EnvNet (end-to-end convolutional neural network for environmental sound classification) and can be trained to extract and learn features of neuroimaging signals unique to various neurological diseases from a massive amount of time-series neuroimaging data.
The team expected that the use of DNN would allow for the system to learn the characteristics of neurological diseases from many signals and classify patients with neurological diseases more accurately than conventional methods using waveforms.
With MNet, they tried to classify neuroimaging big data on 140 patients with epilepsy, 26 patients with spinal cord injuries, and 67 healthy subjects. The trained MNet succeeded in classifying healthy subjects and those with the two neurological diseases with an accuracy of over 70% and patients with epilepsy and healthy subjects with an accuracy of nearly 90%. The classification accuracy was significantly higher than that obtained by a support vector machine (SVM), a conventional general machine learning method based on waveforms (relative band powers of EEG signal). Moving forward, this technique will be used for diagnosis of various neurological diseases, evaluation of severity, prognosis, and efficacy of treatment.
“Machine learning is constantly advancing, with new techniques being developed all the time. However, no matter how much analytical methods advance, if the quality of underlying data is poor, a sharp distinction cannot be drawn. We carried out the process of machine learning by utilizing DNN, which processed big data mainly from the Osaka University Hospital Epilepsy Center. We’d like to increase the number and the types of diseases to be diagnosed without sacrificing quality of data so that our technique will be helpful in clinical practice,” says researcher Jo Aoe of Osaka University.
Learn more: Automatic neurological disease diagnosis using deep learning
The Latest on: Automatic diagnosis system
[google_news title=”” keyword=”automatic diagnosis system” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Automatic diagnosis system
- Automated Microscopy Market Future Revenues to Take Flight as Market Size Continues to Expandon May 9, 2024 at 3:39 pm
The global automated microscopy market, valued at approximately USD 7.1 billion in 2022, is projected to grow at a compound annual growth rate (CAGR) of more than 6.4% from 2023 to 2030. Read the ...
- Biosense introduces CARTO 3 System Version 8on May 9, 2024 at 6:29 am
Cardiac arrhythmia diagnosis and treatment specialist Biosense has launched CARTO 3 System Version 8, a 3D heart mapping system used in cardiac ablation procedures. This latest version introduces new ...
- Accelerate Diagnostics: Q1 Earnings Snapshoton May 8, 2024 at 2:24 pm
(AP) — Accelerate Diagnostics Inc. (AXDX) on Wednesday reported a loss of $17 million in its first quarter. The Tucson, Arizona-based company said it had a loss of 88 cents per share. The maker of ...
- J&J's Biosense Webster brings AI to its heart-mapping Carto 3 systemon May 8, 2024 at 3:15 am
which incorporates electrophysiology features such as the automatic tracking of arrhythmias before and after delivering ablation, and the ability to reproducibly identify critical areas of the heart ...
- Hamilton BiOS Automated Storage Systems to Strengthen UK Biobank’s Efforts Towards Improving Human Healthon May 4, 2024 at 6:48 pm
Enhanced and expanded automated sample storage is central to UK Biobank’s new Manchester Science Park facility.United States - May 4, 2024 — ...
- Semi-automated purification of NGS librarieson May 3, 2024 at 12:56 am
By utilizing the CyBio FeliX benchtop liquid handling system to help automate NGS library preparation, which encompasses bead-based library purification, qPCR setup, and pooling, a sole operator can ...
- Revvity unveils a new era of automated tuberculosis testingon April 26, 2024 at 8:38 am
Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is easy to use and designed to ...
- Using AI to improve diagnosis of rare genetic disorderson April 25, 2024 at 10:46 am
Diagnosing rare Mendelian disorders is a labor-intensive task, even for experienced geneticists. Investigators at Baylor College of Medicine are trying to make the process more efficient using ...
- Cloudflare says it has automated empathy to avoid fixing flaky hardware too oftenon March 26, 2024 at 12:26 am
Error budget' and other server maintenance/site reliability secrets revealed Cloudflare has revealed a little about how it maintains the millions of boxes it operates around the world – including the ...
- Medical diagnosticson March 21, 2024 at 5:46 pm
patented technology that combines high multiplex diagnostic assays with automatic testing systems. Seegene’s syndromic PCR assays identify up to 15 targets with quantitative information in a ...
via Bing News